BENZTROPINE MESYLATE
NDC 10135-813, benztropine mesylate, tablet, from Marlex PHARMACEUTICAL, INC.
- Product NDC
- 10135-813
- Status
- Listed
- Labeler
- Marlex PHARMACEUTICAL, INC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204713
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENZTROPINE MESYLATE.5 mg/1
Pharmacologic classes
Anticholinergic [EPC]; Antihistamine [EPC]; Cholinergic Antagonists [MoA]; Histamine Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-813-01 | 10135081301 | 100 TABLET in 1 BOTTLE (10135-813-01) |
| 10135-813-10 | 10135081310 | 1000 TABLET in 1 BOTTLE (10135-813-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/31bbcbfa-dc74-99e2-e063-6394a90aa608
Use it
Look up 10135-813 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.